Shares of Sunshine Biopharma Inc. (SBFM) are currently up over 40% following the company's announcement of a 45% revenue growth for 2024 and its positive outlook for the near future.
The company filed its 2024 annual report on Form 10-K yesterday, highlighting key figures such as:
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com